Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction.
about
Scaffold Composition Determines the Angiogenic Outcome of Cell-Based Vascular Endothelial Growth Factor Expression by Modulating Its Microenvironmental Distribution.Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy.The Effect of Pulsatile Flow on bMSC-Derived Endothelial-Like Cells in a Small-Sized Artificial Vessel Made by 3-Dimensional Bioprinting.Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model
P2860
Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Targeted Genome Engineering to ...... ment of Myocardial Infarction.
@ast
Targeted Genome Engineering to ...... ment of Myocardial Infarction.
@en
type
label
Targeted Genome Engineering to ...... ment of Myocardial Infarction.
@ast
Targeted Genome Engineering to ...... ment of Myocardial Infarction.
@en
prefLabel
Targeted Genome Engineering to ...... ment of Myocardial Infarction.
@ast
Targeted Genome Engineering to ...... ment of Myocardial Infarction.
@en
P2093
P2860
P356
P1476
Targeted Genome Engineering to ...... ment of Myocardial Infarction.
@en
P2093
Byung-Jae Kang
Hyun-Kyung Chang
Hyun-Min Cho
Je-Yoel Cho
Joo-Hyun Kim
Kwaku Bonsra
Min-Cheol Choi
Pyung-Hwan Kim
So-Yeong Lee
P2860
P304
P356
10.1002/SCTM.16-0114
P50
P577
2017-01-03T00:00:00Z